For the second month in a row the FDA pushed through five new drug approvals. This was accomplished by a surge of activity during the last week of the month for cancer and migraine drugs. The FDA rejected one drug, and another failed to produce its expected results. There were updates to nine drugs with PDUFA Dates and Priority Designations (potential budget busters). Read on for the details.
31 citations were added to our knowledgebase bringing the total to 811. Each citation is accessible from the single drug look-up monograph via a URL link to the publication. There are now 612 investigational drugs in the Knowledgebase.
We launched our new “use us when you need us” subscription plans. Click on this link for a preview. https://www.prescriberight.com/access-pharmaceutical-pipeline-tracker.html
Here are three additional links to the Use Cases we’ve developed: https://www.prescriberight.com/monitoring-drugs-with-pdufa-dates.html
How to gather information about Right to Try requests: https://www.prescriberight.com/research-a-single-drug.html
Stay informed, subscribe to the
Prescribe Right Pharmaceutical Pipeline Tracker
Latest Tweets from Prescribe Right